Market Closed -
Other stock markets
|
After market 15:59:53 | |||
3.226 EUR | -2.24% |
|
3.291 | +2.01% |
07-01 | Valneva's Secures Marketing Authorization in Europe for Chikungunya Vaccine | MT |
07-01 | New semester, new state of mind | ![]() |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-31.65% | 493M | |
+16.59% | 44.87B | |
-10.62% | 37.8B | |
+40.49% | 37.61B | |
+29.92% | 31.32B | |
-9.78% | 27.4B | |
+12.34% | 26.32B | |
+41.53% | 14.07B | |
+31.49% | 12.5B | |
-7.40% | 11.23B |
- Stock Market
- Equities
- VLA Stock
- News Valneva
- Valneva's Secures Marketing Authorization in Europe for Chikungunya Vaccine